Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Cagossi · SciRah

Researcher profile · Semantic Scholar

K. Cagossi

Share profile

K. Cagossi — researcher profile on SciRah

h-index: 20
Works: 99
Citations: 1,936

Most-cited papers

Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: results of the randomized phase II CHER-LOB study.
V. Guarneri, A. Frassoldati, A. Bottini, K. Cagossi +17 more
2012Journal of Clinical Oncology341 citations Open access
Semantic Scholar
Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura.
G. Emilia, Giuseppe Longo, M. Luppi, G. Gandini +5 more
2001Blood254 citations Open access
Semantic Scholar
Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia
A. Decensi, M. Puntoni, A. Guerrieri-Gonzaga, S. Caviglia +18 more
2019Journal of Clinical Oncology169 citations Open access
Semantic Scholar
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡
P. Conte, A. Frassoldati, G. Bisagni, A. Brandes +80 more
2018Annals of Oncology153 citations Open access
Semantic Scholar
Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast Cancer.
V. Guarneri, M. Dieci, A. Frassoldati, A. Maiorana +12 more
2015The Oncologist102 citations Open access
Semantic Scholar
Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Recurrence in Breast Noninvasive Neoplasia: A 10-Year Follow-Up of TAM-01 Study
M. Lazzeroni, M. Puntoni, A. Guerrieri-Gonzaga, D. Serrano +19 more
2023Journal of Clinical Oncology77 citations Open access
Semantic Scholar
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer
M. Dieci, P. Conte, G. Bisagni, A. Brandes +18 more
2019Annals of Oncology77 citations Open access
Semantic Scholar
Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00.
M. Colleoni, K. Gray, S. Gelber, I. Láng +18 more
2016Journal of Clinical Oncology74 citations Open access
Semantic Scholar
Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy.
Roberto Sabbatini, M. Federico, M. Morselli, R. Depenni +4 more
2000Journal of Clinical Oncology55 citations Open access
Semantic Scholar
Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer.
V. Guarneri, D. Generali, A. Frassoldati, F. Artioli +16 more
2014Journal of Clinical Oncology53 citations Open access
Semantic Scholar
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study.
M. Cazzaniga, Graziella Pinotti, E. Montagna, D. Amoroso +67 more
2019Breast49 citations
Semantic Scholar
Final results of a phase II randomized trial of neoadjuvant anthracycline-taxane chemotherapy plus lapatinib, trastuzumab, or both in HER2-positive breast cancer (CHER-LOB trial).
V. Guarneri, A. Frassoldati, A. Bottini, Daniele Generali +16 more
2011Journal of Clinical Oncology36 citations Open access
Semantic Scholar
Trastuzumab-lapatinib as neoadjuvant therapy for HER2-positive early breast cancer: Survival analyses of the CHER-Lob trial.
V. Guarneri, M. Dieci, G. Griguolo, F. Miglietta +14 more
2021European Journal of Cancer35 citations Open access
Semantic Scholar
Incidence of breast cancer in Italy: mastectomies and quadrantectomies performed between 2000 and 2005
P. Piscitelli, A. Santoriello, F. Buonaguro, M. di Maio +14 more
2009Journal of experimental & clinical cancer research : CR26 citations Open access
Semantic Scholar
Changes in Cancer Patients' and Caregivers' Disease Perceptions While Receiving Early Palliative Care: A Qualitative and Quantitative Analysis
Eleonora Borelli, Sarah Bigi, L. Potenza, Sonia Eliardo +20 more
2021The Oncologist25 citations Open access
Semantic Scholar
Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer
A. Musolino, Nadia Naldi, M. Dieci, D. Zanoni +13 more
2016The Pharmacogenomics Journal25 citations Open access
Semantic Scholar
Scalp Cooling in Daily Clinical Practice for Breast Cancer Patients Undergoing Curative Chemotherapy: A Multicenter Interventional Study
E. Gianotti, G. Razzini, M. Bini, C. Crivellaro +8 more
2019Asia-Pacific Journal of Oncology Nursing24 citations Open access
Semantic Scholar
Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials
M. Dieci, A. Frassoldati, Daniele Generali, G. Bisagni +12 more
2017Breast Cancer Research and Treatment23 citations Open access
Semantic Scholar
Effect Modifiers of Low-Dose Tamoxifen in a Randomized Trial in Breast Noninvasive Disease
A. Decensi, M. Puntoni, H. Johansson, A. Guerrieri-Gonzaga +17 more
2021Clinical Cancer Research21 citations Open access
Semantic Scholar
Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer
G. Griguolo, M. Dieci, L. Paré, F. Miglietta +11 more
2021npj Breast Cancer21 citations Open access
Semantic Scholar
Perceptions of Death Among Patients with Advanced Cancer Receiving Early Palliative Care and Their Caregivers: Results from a Mixed-Method Analysis
Sarah Bigi, Vittorio Ganfi, Eleonora Borelli, L. Potenza +19 more
2022The Oncologist19 citations Open access
Semantic Scholar
Expression of cell-homologous genes of human herpesvirus-8 in human immunodeficiency virus-negative lymphoproliferative diseases.
M. Luppi, P. Barozzi, A. Maiorana, R. Trovato +4 more
1999Blood19 citations
Semantic Scholar
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study
M. Cazzaniga, I. Vallini, E. Montagna, D. Amoroso +45 more
2021Breast Cancer Research and Treatment16 citations Open access
Semantic Scholar
PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2+ Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype
V. Guarneri, M. Dieci, G. Bisagni, A. Brandes +19 more
2020Clinical Cancer Research16 citations Open access
Semantic Scholar
Preoperative Carboplatin–Paclitaxel–Bevacizumab in Triple-Negative Breast Cancer: Final Results of the Phase II Ca.Pa.Be Study
V. Guarneri, M. Dieci, G. Bisagni, C. Boni +5 more
2015Annals of Surgical Oncology16 citations Open access
Semantic Scholar
Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early ERBB2-Positive Breast Cancer
M. Dieci, G. Bisagni, S. Bartolini, A. Schirone +18 more
2025JAMA Oncology15 citations Open access
Semantic Scholar
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial
M. Dieci, G. Bisagni, A. Brandes, A. Frassoldati +28 more
2019BMC Medicine15 citations Open access
Semantic Scholar
A late complication of fat autografting in breast augmentation.
M. Lazzaretti, G. Giovanardi, F. Gibertoni, K. Cagossi +1 more
2009Plastic and Reconstructive Surgery12 citations Open access
Semantic Scholar
Immunoglobulin mutational status detected through single-round amplification of partial V(H) region represents a good prognostic marker for clinical outcome in chronic lymphocytic leukemia.
R. Marasca, Rossana Maffei, M. Morselli, P. Zucchini +9 more
2005Journal of Molecular Diagnostics12 citations Open access
Semantic Scholar
The oncogenic 30 and 69 bp deletion variants of the EBV LMP-1 gene are common in HIV-negative lymphoproliferations, both malignant and benign.
P. Barozzi, M. Luppi, K. Cagossi, A. Maiorana +5 more
1999Annals of Oncology12 citations Open access
Semantic Scholar
The impact of the SARS-COV-2 pandemic on the quality of breast cancer care in EUSOMA-certified breast centres
P. V. van Dam, M. Tomatis, A. Ponti, L. Marotti +52 more
2022European Journal of Cancer10 citations Open access
Semantic Scholar
Different semantic and affective meaning of the words associated to physical and social pain in cancer patients on early palliative/supportive care and in healthy, pain-free individuals
Eleonora Borelli, Sarah Bigi, L. Potenza, F. Artioli +14 more
2021PLoS ONE10 citations Open access
Semantic Scholar
Safety profile of subcutaneous trastuzumab for the treatment of patients with HER2-positive early or locally advanced breast cancer: primary analysis of the SCHEARLY study.
M. Zambetti, F. Montemurro, P. Morandi, C. Zamagni +8 more
2018European Journal of Cancer10 citations
Semantic Scholar
Safety and Activity Report of a Randomized Phase II Trial of Preoperative Anthracycline-Based Chemotherapy Plus Lapatinib, Trastuzumab or Both in HER2 Positive Breast Cancer: CHERLOB Trial.
V. Guarneri, A. Frassoldati, A. Bottini, K. Cagossi +7 more
20099 citations Open access
Semantic Scholar
Oncoplastic and reconstructive surgery in SENONETWORK Italian breast centers: lights and shadows
M. Ghilli, A. Lisa, M. Salgarello, G. Papa +110 more
2023Breast7 citations Open access
Semantic Scholar
Abstract GS3-01: A randomized placebo controlled phase III trial of low dose tamoxifen for the prevention of recurrence in women with operated hormone sensitive breast ductal or lobular carcinoma in situ
A. Decensi, M. Puntoni, A. G. Gonzaga, F. Avino +13 more
2019General Session Abstracts7 citations
Semantic Scholar
Abstract PD1-1: Tumor infiltrating lymphocytes and correlation with outcome in the Cher-LOB study
M. Dieci, G. Bisagni, K. Cagossi, A. Bottini +4 more
20157 citations Open access
Semantic Scholar
Preplanned first-step analysis of LET-LOB neoadjuvant study: A double-blind randomized phase IIb trial of letrozole (L) plus lapatinib (Lp) or placebo (P) in postmenopausal HER2-ve, HR+ve operable breast cancer.
A. Frassoldati, Valentina Guarneri, A. Bottini, K. Cagossi +6 more
2009Journal of Clinical Oncology7 citations Open access
Semantic Scholar
CHER LOB Trial: Preoperative chemotherapy plus trastuzumab, lapatinib or both in HER2-positive operable breast cancer—Safety report as per Independent Data Monitoring Committee (IDMC) and preliminary activity data
V. Guarneri, A. Frassoldati, K. Cagossi, A. Bottini +6 more
20087 citations Open access
Semantic Scholar
Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients
B. Trevisan, F. Pepe, I. Vallini, E. Montagna +42 more
2023Scientific Reports6 citations Open access
Semantic Scholar
Rare Case of Male Breast Cancer and Axillary Lymphoma in the Same Patient: An Unique Case Report
E. Sordi, K. Cagossi, M. Lazzaretti, D. Gusolfino +4 more
2011Case Reports in Medicine6 citations Open access
Semantic Scholar
Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial.
H. Johansson, D. Macis, Martino Oliva, M. Puntoni +18 more
2025Clinical Cancer Research5 citations
Semantic Scholar
CHER-LOB: PREOPERATIVE CHEMOTHERAPY PLUS TRASTUZUMAB, LAPATINIB OR BOTH IN HER2-POSITIVE OPERABLE BREAST CANCER – PRELIMINARY SAFETY REPORT WITH FOCUS ON CARDIAC TOLERABILITY
V. Guarneri, A. Frassoldati, K. Cagossi, A. Bottini +6 more
20075 citations
Semantic Scholar
Lapatinib or placebo plus letrozole as preoperative treatment of hormone receptor-positive HER2-negative operable breast cancer. Preliminary report of safety and activity of the double-blind randomized phase IIb LET-LOB study
A. Frassoldati, V. Guarneri, A. Bottini, K. Cagossi +6 more
20084 citations Open access
Semantic Scholar
Basal-like HR + /HER2- breast cancers show higher tumor-infiltrating lymphocytes and immune signatures with potential therapeutic implications
G. Griguolo, M. Bottosso, L. Paré, F. Miglietta +15 more
2025npj Breast Cancer3 citations Open access
Semantic Scholar
19P PIK3CA mutations in HER2-positive early breast cancer patients enrolled in the adjuvant randomized short-HER study
V. Guarneri, M. Dieci, G. Bisagni, A. Brandes +16 more
20203 citations Open access
Semantic Scholar
Effect modifiers in a randomized phase III trial of low-dose tamoxifen in breast preinvasive disease.
A. de Censi, M. Puntoni, A. Guerrieri-Gonzaga, S. Caviglia +16 more
2019Journal of Clinical Oncology3 citations
Semantic Scholar
Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): What has changed over the time? Preliminary results of the VICTOR-6 study
M. Cazzaniga, V. Casadei, K. Cagossi, L. Cavanna +16 more
20173 citations
Semantic Scholar
Randomized, placebo controlled, phase III trial of low-dose tamoxifen in women with intraepithelial neoplasia.
M. Puntoni, B. Bonanni, G. d'Aiuto, A. Ponti +16 more
20133 citations
Semantic Scholar
thrombocytopenic purpura eradication can induce platelet recovery in idiopathic Helicobacter pylori
S. Amarri, K. Cagossi, G. Emilia, G. Longo +3 more
20113 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Piacentini×21
Invite
F. Piacentini — researcher profile on SciRah
V. Guarneri×20
Invite
V. Guarneri — researcher profile on SciRah
G. Bisagni×18
Invite
G. Bisagni — researcher profile on SciRah
A. Frassoldati×17
Invite
A. Frassoldati — researcher profile on SciRah

×17

Invite

L. Cavanna — researcher profile on SciRah

A. Musolino×16

Invite

A. Musolino — researcher profile on SciRah

Invite

P. Conte — researcher profile on SciRah

Invite

M. Dieci — researcher profile on SciRah

Invite

S. Sarti — researcher profile on SciRah

Invite

F. Artioli — researcher profile on SciRah

Invite

O. Garrone — researcher profile on SciRah

Invite

A. Bottini — researcher profile on SciRah